Rep. Seo Young-seok says the drugs escape DUR checks, so long supplies and combos with phentermine trigger no warnings. He wants tighter monitoring.
Recap by typeshit. Full story at Sports Chosun.
The actor backed Ozempic in an interview while saying exercise has no shortcut. Doctors break down whether his advice holds up.
A BusinessWorld piece on FDA worries about unapproved GLP-1 weight loss drugs, including retatrutide, which is still in trials. Few details were available.
Hecht walks through studies raising concerns that Ozempic and Wegovy may be tied to a rare optic nerve problem that can affect vision.
After his appetite disappeared on tirzepatide, Krasno talks with the Your Best Shot author about food and why scale weight can mask muscle, bone and testosterone loss.
Researchers found people on GLP-1 medications for weight loss or diabetes reported hair loss and nails lifting off more often than people who never used them.
Korean adverse event figures show hundreds of patients on Wegovy or Mounjaro shots were treated for acute pancreatitis or gallstones, SBS reports.
Loading…